Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 4, 2012, Pages 299.e1-299.e7

  Okoroh, Ekwutosi M ^a   Hooper, W Craig ^a   Atrash, Hani K ^a   Yusuf, Hussain R ^a   Boulet, Sheree L ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

phenotype; polycystic ovary syndrome; prevalence

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; UNITED STATES;

EID: 84866909801     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.07.023     Document Type: Article

References (14)

1. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
2. E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
3. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
4. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
5. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544 551
6. R. Azziz, E. Carmina, D. Dewailly Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245
7. F.J. Broekmans, E.A. Knauff, O. Valkenburg, J.S. Laven, M.J. Eijkemans, B.C. Fauser PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors BJOG 113 2006 1210 1217
8. T. DiMarcantonio Clinical news on diabetes and endocrine disorder: controversy around the definition of PCOS continues Endocrine Today 2008 http://www.healio.com/endocrinology/reproduction-androgen-disorders/news/print/ endocrine-today/%7BA96B526F-5773-44B1-9E74-C96788606261%7D/Controversy-around- the-definition-of-PCOS-continues Accessed Aug. 17, 2012
9. K.J. Mather, F. Kwan, B. Corenblum Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity Fertil Steril 73 2000 150 156
10. E.O. Talbott, D.S. Guzick, K. Sutton-Tyrrell Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women Arterioscler Thromb Vasc Biol 20 2000 2414 2421
11. D.M. Adamson, S. Chang, L.G. Hansen Health research data for the real world: the MarketScan Databases 2008 Thomson Reuters New York, NY
12. H. Petri, D. Maldonato, N.J. Robinson Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database BMC Musculoskelet Disord 11 2010 247
13. J.C. Lo, S.L. Feigenbaum, J. Yang, A.R. Pressman, J.V. Selby, A.S. Go Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 1357 1363
14. H. Quan, B. Li, L.D. Saunders Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database Health Serv Res 43 2008 1424 1441